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Abstract
Background: The epicardium has key functions during myocardial development, by contributing to the formation of
coronary endothelial and smooth muscle cells, cardiac fibroblasts, and potentially cardiomyocytes. The epicardium plays a
morphogenetic role by emitting signals to promote and maintain cardiomyocyte proliferation. In a regenerative context, the
adult epicardium might comprise a progenitor cell population that can be induced to contribute to cardiac repair. Although
some genes involved in epicardial function have been identified, a detailed molecular profile of epicardial gene expression
has not been available.
Methodology: Using laser capture microscopy, we isolated the epicardial layer from the adult murine heart before or after
cardiac infarction in wildtype mice and mice expressing a transgenic IGF-1 propeptide (mIGF-1) that enhances cardiac
repair, and analyzed the transcription profile using DNA microarrays.
Principal Findings: Expression of epithelial genes such as basonuclin, dermokine, and glycoprotein M6A are highly enriched
in the epicardial layer, which maintains expression of selected embryonic genes involved in epicardial development in
mIGF-1 transgenic hearts. After myocardial infarct, a subset of differentially expressed genes are down-regulated in the
epicardium representing an epicardium-specific signature that responds to injury.
Conclusion: This study presents the description of the murine epicardial transcriptome obtained from snap frozen tissues,
providing essential information for further analysis of this important cardiac cell layer.
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Introduction
The epicardium is a single epithelial cell layer overlying the
vertebrate heart. It derives from the proepicardium that gives rise
to the vasculature and interstitial cells of the heart during
embryogenesis, a process that is mandatory for normal develop-
ment [1,2,3,4]. It is still under debate if the epicardium also gives
rise to endothelial cells of the vasculature [5,6] and if it contributes
to the myocardium directly [1,2,7]. Deletions of selected genes
expressed in the epicardium (i.e. VCAM-1, a4-integrin) or
signalling from the myocardium to the epicardium (i.e. Tb4,
FOG-2) lead to severe defects in the developing heart and its
vasculature [3,6].
Beyond its role during cardiac development, the epicardium
also mediates cardiac regeneration after injury in lower verte-
brates. Specifically, the zebrafish epicardium supports cardiac
regeneration through epithelial to mesenchymal transition (EMT)
and subsequent migration into the myocardium to form new
vasculature [8]. In mammals, these regenerative processes are not
active to the degree that they support recovery of infarcted
myocardial tissue. Instead, myocardial infarction is followed by
inflammation and scarring. The fibrotic tissue is not able to
support normal cardiac function, which in many cases leads to
cardiac failure. However, the epicardium does retain some
capability to be involved in repair processes also in mammals, in
that for example Thymosin beta-4 can activate adult epicardial
cells [9] acting through reactivation of embryonic signalling
pathways [10]. This thymosin mediated activation of epicardial
cells can in fact support revascularization of the injured
mammalian heart by forming endothelial and vascular smooth
muscle cells [11]. Further, a sub-population of adult epicardial
cells retains the potential to give rise to cardiac precursors or
endothelial cells [12]. The regenerative potential of the epicardium
has also prompted several other strategies to improve mammalian
cardiac regeneration, including the injection of epicardium-
derived cells (EPDCs) into the injured myocardium, which was
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clinical importance [13]. In newer studies cardiomyocyte progeni-
tors were cotransplanted with EPDCs into infarcted myocardial
tissues, which improved functional repair when compared to single
cell type supplementation [14]. The effect however was shown to
be caused by paracrine effects from both cell types.
Although some of the genes involved in epicardial function have
been identified and characterised [15,16,17], comprehensive
transcriptional analyses of the adult mammalian epicardium have
been lacking. In this study, we employed laser capture microscopy
(LCM) on snap frozen tissues to obtain unaltered epicardial
sample. This micro-dissection technique afforded a very precise
excision of the epicardial layer without prior modification, such as
labelling of epicardial cells, which may compromise RNA quality;
without cell sorting, which might isolate only a particular cell
fraction; and without cell culturing, thereby avoiding inevitable
changes in gene expression.
Using this approach, we identified numerous genes that have
not previously been implicated in the function, homeostasis, or
regeneration of the epicardium or the heart. Our results provide
several markers of the steady state adult epicardium, and changes
of epicardial signature gene expression in response to LCA injury
that underscore the involvement of the epicardium after cardiac
damage. Epicardial signature gene expression patterns were
altered in a model of enhanced cardiac regeneration by delivery
of a localized transgenic IGF-1 propeptide, which reactivated
genes implicated in the effective regenerative response of other
vertebrate species. This study provides a wealth of information on
gene expression patterns in this important tissue, which will prove
potentially valuable in future studies of epicardial function in
cardiac homeostasis and infarction models.
Results
Transcripts encoding several genes are enriched in the
epicardium
Using LCM technology, we isolated the left ventricular
epicardial layer of frozen murine hearts as described in Materials
and Methods (Figure S1), resulting in an epicardium-enriched
sample. RNA isolated from epicardial and underlying myocardial
tissue samples were compared by DNA microarray analysis (Array
Express: E-MEXP-2446). To gain an overview of differential gene
expression between the epicardial and muscle control samples, we
performed an unsupervised analysis of the gene array data (SOM
262). This resulted in four clusters (Figure 1-A). The first cluster
was populated by genes that were higher in epicardial samples
than in muscle samples, the second and third cluster were mainly
unchanged among the samples, and the fourth cluster contained
genes that were higher in the non-epicardial muscle control
samples. To establish criteria for epicardial genes we applied
conditions based on Cluster 1, to define genes that are highly
expressed in the epicardium but not in the muscle controls thus
representing the epicardial signature genes, as described in
Materials and Methods (Table 1, Table S1). These genes are also
shown as a heat map (Figure 1-B).
As a separate quality control, we also compared the epicardial
sample to left ventricle or whole heart tissues [18], by comparing
existing gene array data and applying the criteria for epicardial
genes (starting from all genes, t-test, multiple testing correction, 4
fold upregulation, raw in epicardium above 20) to the pairs:
epicardium/heart, epicardium/left ventricle, and epicardium/
muscle control. We then compared the resulting lists of epicardial
signature genes. Although the lists were not identical, especially for
the highly epicardium specific genes, the results were consistent, in
thatthegenesfromouroriginalepicardialsignaturegenesinTable1
(epicardial with .25 fold induction in the epicardium) were all
found in all three lists of epicardial genes (Figure S2, Table S2).
Differences were mainly observed in genes with lower induction.
This analysis uncovered numerous epicardial signature genes
such as uroplakin 1b, 3b, glycoprotein m6a, dermokine or
basonuclin that have not previously been implicated in the
function, homeostasis or regeneration of the epicardium or the
heart. Importantly, our list of epicardial signature genes also
contained several genes whose expression have previously
documented in the epicardium, playing key roles in epicardial
development. Among these were RALDH2 (9 fold increase) the
earliest retinoic synthetic enzyme in the embryo and implicated in
mammalian epicardial contribution to the coronary vasculature
and myocardial repair in the zebrafish system [8,19,20,21]. The
previously documented expression of Tbx18 in epicardial cells as
well as epicardial progenitors [2], also validates the epicardial
identity of our signature gene collection. Selective quantitative
RT-PCR analysis for dermokine, basonuclin-1, Efemp-1, proline
rich 15, sulfatase 1, and uroplakin-3b transcripts, confirmed
epicardial enrichment (Figure 2-A). To confirm these observations
on the protein level, immunohistochemical analysis localized
dermokine, basonuclin-1, and GPM6A to the epicardium
(Figure 2-B,C).
Systematic analysis of tissue expression profiles by comparing
the list of epicardium-enriched transcripts to relevant gene
ontology lists (GO: 8150; biological process, see Materials and
Methods), revealed mainly immune system-related lists (i.e. GO:
2526, 2541, 6956, 6692, 45087, 6959) with very low p-values.
Notably, the list for extracellular matrix organization (GO: 30198)
as well as the cell adhesion and biological adhesion lists (GO:
7155, 22610) also had a high similarity (p,0.0005) to the
epicardial gene list from normal (un-injured) hearts (Table 2,
Table S3).
Epicardial genes are differentially regulated after
myocardial infarction
To assess the early changes in epicardial gene expression in
response to injury, we collected hearts from a mouse model of
myocardial infarction induced by left coronary artery ligation
(LCA) and compared to those of non-infarcted (sham operated)
mice. Epicardial samples and muscle controls for both conditions
were obtained using LCM as described above, and changes in
expression levels were analyzed six days after myocardial
infarction using gene arrays. SOM cluster analysis as described
in Materials and Methods for the previously determined epicardial
genes (Figure 3-A), are summarized in a heat map (Figure 3-B).
Among the six obtained clusters, Cluster 3 contained 53 epicardial
signature genes that decreased steeply after infarction, with only
slight changes in the underlying cardiac muscle control samples.
Conversely, Cluster 4 contained 82 signature genes whose
expression was relatively stable for the epicardial samples, while
their expression in underlying muscle increased significantly after
infarction. The remaining clusters contained mainly slight
variations of these two patterns, or no significant changes. We
carried out statistical analysis for Clusters 3 and 4, resulting in a list
of 23 signature genes from Cluster 3 that were significantly
downregulated in the epicardial samples (Table 3) and a list of 21
signature genes from Cluster 4 that were significantly upregulated
in the muscle samples post-infarction (Table 4). When carrying out
GO ontology analysis on the list of Cluster 3 signature genes
downregulated in the infarcted epicardium, we observed similar
enrichment of GO lists as for the initial epicardial gene analysis,
such as acute inflammatory response (GO:2526), complement
Epicardial Transcriptomics
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inflammatory response (GO:2541) (Table S4). These lists were
consistently populated by complement-related genes and many of
the signature genes enriched in the uninjured epicardium (11
downregulated genes were among those 26 signature genes with a
fold difference above 25, while the other 12 were among the
remaining 171 signature genes with a lower fold induction).
Interestingly, GO ontology analysis for epicardial signature
genes upregulated in the muscle control revealed a distinctly
different set of lists (Table S5) resembling mainly developmental
and vascularisation processes. Among these, some of the highest
ranking lists were collagen fibril organization (GO:301099),
extracellular matrix organization (GO:30198), skin morphogenesis
(GO:43589), vasculature development (GO:1944), epidermis
Figure 1. Unsupervised analysis of epicardial gene expression. A self organizing map was used as an unsupervised analysis tool to simplify
complex expression information. B) x-axis are relative normalized expression of epicardium samples, y-axis are relative normalized expression of
muscle samples. The four resulting clusters represent generally different expression patters rather than their absolute expression values. Cluster 1
contains genes that were higher in the epicardial samples than in the muscle controls. Clusters 2 and 3 contains genes that were similar in expression
in epicardium and muscle. Cluster 4 contains genes that were higher in the muscle controls than in the epicardial samples. B) Starting from Cluster 1,
we applied conditions as described in Materials and Methods to select 197 epicardial signature genes shown as a heat map. The top four rows are
epicardial samples, and the lower four rows are muscle control samples, where green colour represents upregulation and red colour represents
downregulation of a given gene.
doi:10.1371/journal.pone.0011429.g001
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Among the highly specific epicardium signature genes, which were
downregulated post-infarct, only one of the epicardial signature
genes was increased in the muscle post-infarct (Riken
1500015O10, induction of 31 fold).
We also examined a selected subset of epicardial genes most
significantly affected by infarction for further analysis at an earlier
time point (three days post-infarction). RT-PCR analysis of three
and six day post-infarction epicardial samples showed a consistent
downregulation of uroplakin 3b, proline rich 15, dermokine,
Efemp-1, sulfatase-1, and basonuclin compared to sham operated
hearts (Figure S3). Conversely, CD5L was strongly upregulated 3
days post infarction but subsided at six days, highlighting the
importance of immune system related genes in early infarct
response processes, and confirming the specificity of changes are in
the post-infarct epicardium.
Regarding less dramatically affected genes than the epicardial
signature subset, we observed a trend towards up-regulation of
vimentin, fibronectin, snail2, and MMP-2 as well as a modest
down-regulation of desmoplakin in the epicardial transcriptome
after injury (data not shown), all of which are associated with cells
undergoing epithelial-to-mesenchymal transition [22]. Thymosin
b-4, a protein implicated in the activation and mobilization of
adult epicardial cells [9], and Thymosin b-10, a potent inhibitor of
angiogenesis [23], were both slightly increased (data not shown).
Similar changes were observed in the underlying cardiac muscle
samples, indicating a general response of these genes to injury.
Epicardial expression changes in mIGF-1 enhanced
cardiac regeneration
We have previously shown that supplemental transgenic expres-
sion of a locally acting Insulin-like Growth Factor-1 propeptide
(mIGF-1) in cardiomyocytes improved repair of the heart after
infarction. Restoration of cardiac form and function in post-infarct
mIGF-1 transgenic mice was facilitated by modulation of the
inflammatory response [30]. To determine how cardiac mIGF-1
expression changes the transcription profile of the pre- and post-
infarct epicardium, we compared the expression of mIGF-1
Table 1. Epicardial Genes.
Fold difference Gene Bank accesion Gene Symbol Gene Description
269.6 BQ084786 Upk3b uroplakin 3B
199.4 BB348674 Gpm6a glycoprotein m6a
129.8 BI452905 Dmkn dermokine
88.97 AV290571 C2 complement component 2 (within H-2S)
81.48 BB427704 Upk1b uroplakin 1B
76.86 NM_026228 Slc39a8 solute carrier family 39 (metal ion transporter), member 8
68.68 AK004699 Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1
56.12 BB118542 Slc26a3 solute carrier family 26, member 3
53.11 BB325766 Lrrn4 leucine rich repeat neuronal 4
45.18 NM_031170 Krt8 keratin 8
45.14 NM_011315 Saa3 serum amyloid A 3
42.83 NM_008471 Krt19 keratin 19
37.65 AW556821 2610018G03Rik RIKEN cDNA 2610018G03 gene
36.93 NM_013473 Anxa8 annexin A8
35.12 K02782 C3 complement component 3
33.93 AJ132433 Prr15 proline rich 15
33.63 BB805362 Slc9a3r1 solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1
31.76 BC005611 Chi3l1 chitinase 3-like 1
31.32 BB392676 1500015O10Rik RIKEN cDNA 1500015O10 gene
30.71 U88064 Bnc1 basonuclin 1
29.94 AK003577 Muc16 mucin 16
28.49 NM_008344 Igfbp6 insulin-like growth factor binding protein 6
28.24 BC023060 Efemp1 epidermal growth factor-containing fibulin-like extracellular matrix protein 1
26.95 NM_021426 Nkain4 Na+/K+ transporting ATPase interacting 4
26.57 BC015076 Mpzl2 myelin protein zero-like 2
26.08 AI852300 Ildr2 immunoglobulin-like domain containing receptor 2
… ………
8.79 NM_00902 Aldh1a2 Aldehyde dehydrogenase family 1
5.15 AK012980 Tbx18 T-box18
List of epicardial genes expressed in epicardial samples isolated by LCM as described in Materials and Methods. Genes from Cluster 1 (from Figure 1), were selected for
statistically significant upregulation in the epicardial samples, a normalized .4-fold increased expression in the epicardial sample compared to the muscle control and
raw expression of at least 20 in the epicardial samples. This selection identified 197 unique epicardial signature genes. This Table includes top hits with a cut off at 25
fold induction in epicardial samples plus two selected epicardial genes with lower induction.
doi:10.1371/journal.pone.0011429.t001
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hearts. In analyses of the mIGF-1 signature gene list (Table S6) by
GO ontology, genes that were found only in the mIGF-1 epicardium
were represented in RNA processing GO lists such as mRNA
processing (GO: 6397) or mRNA metabolic processes (GO: 16071),
in contrast to genes only in the wildtype epicardium represented in
acute inflammatory response (GO:2526), complement activation
(GO: 2541), or innate immune response (GO: 45087).
Although the most highly expressed genes of the unperturbed
epicardium were common to both genotypes, several genes were
selectively upregulated in the epicardium of mIGF-1 animals.
Comparing wildtype and mIGF-1 samples revealed a number of
genes that were highly epicardium specific in the mIGF-1 samples but
that were not part of the epicardial signature in the wildtype mice
(Table 5). Furthermore, two known epicardial genes were increased
in the epicardium of mIGF-1 transgenic mice when compared to
wildtype samples, namely Tbx18 (8.5 fold increase) and RALDH2
(40 fold increase). Thus, the epicardium of mIGF-1 transgenic mice
differs in its normal gene expression profile from the wildtype hearts,
suggesting a role for the epicardium in the regenerative effects of
mIGF-1 expression from the underlying myocardium.
To test this possibility, we compared the expression profiles of
the wildtype and mIGF-1 hearts six days post infarction.
Interestingly, the post-infarction gene expression changes seen in
wildtype animals were less evident in the mIGF-1 hearts:
unsupervised analysis of mIGF-1 epicardial genes using SOM
revealed no cluster with significant changes of expression
(Figure 4), indicating that the action of mIGF-1 alleviates the
transcriptional perturbations caused by myocardial infarction.
Discussion
The relative paucity of cell-restricted markers represents a
current constraint on physiological and pathophysiological studies
Figure 2. Confirmation of epicardial gene expression. A) qRT-PCR was used to confirm gene array data, normalized against 18 S expression.
Statistical significance was tested using the student t-test. Expression levels for uroplakin 3b, basonuclin 1, proline rich 15, dermokine, Efemp1, and
sulfatase were significantly upregulated in the epicardial samples. GAPDH, RMPS2, and CD5L serve as controls; GAPDH was expressed higher in
muscle tissue while RMPS2 and CD5L showed no statistically relevant expression in the different samples as expected. B,C) Using
immunohistochemical localization of glycoprotein M6A (B), dermokine (C), and basonuclin-1 (D) proteins in the epicardial or subepicardial layer.
(* denotes statistical significance with p,0.05, **: p,0.005, ***: p,0.0005; Error bars are S.E.M., scale bars are 100 microns).
doi:10.1371/journal.pone.0011429.g002
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elucidating epicardial marker genes is a powerful way to obtain
better insight into the expression profile and characteristics of the
epicardial layer. Using laser capture microscopy, we developed an
analytical approach for the identification of novel epicardial genes,
yielding a list of potentially interesting genes for epicardial function
that has not been possible with more traditional, less high-
throughput approaches. The use of LCM affords the unbiased
collection of the entire cell population of the epicardium/
subepicardium as opposed to more selective cell sorting or
staining-based technologies. Although we confirmed the micro-
array results for an epicedial signature gene subset at the protein
level, any analysis based on RNA-transcripts has its limitations,
and more extensive validation of protein expression will be
necessary when examining other genes contained in these lists.
Other approaches have compared gene expression of epicardial
regions to endocardial regions of the ventricular wall of the rat
[24], in this study we focus on the comparison of gene expression
of the murine epicardium to the ventricular wall before or after left
coronary artery ligation (LCA).
The epicardial transcriptomic analysis presented here high-
lighted cell adhesion genes characteristic of epithelia, confirm-
ing a characterization of the epicardium as an epithelial cell
layer covering the heart. On a broader scale, the GO ontology
analysis confirms the epithelial character of the epicardium, as
exemplified by numerous candidates in the cell adhesion list.
Other high scoring GO lists were mainly related to immune
response, populated with complement-related genes that are
normally expressed in epithelial cells such as keratinocytes of the
skin [25] or intestinal epithelial cell lines [26]. The down-
regulation of these epicardial related immune system genes after
infarction further suggests that the epicardium normally
expresses immune system-related genes to form a barrier
protecting the heart. Of note, an enrichment of GO ontology
lists based on the epicardial genes in the infarcted muscle tissue
related to developmental processes and particularly in vascular-
isation and epithelial formation.
Of the novel epithelial genes identified in this study, dermokine
and basonuclin are particularly noteworthy in the context of the
adult epicardium. Importantly, these genes have been described as
epithelial genes in the literature, but heretofore have not been
annotated as such in the GO ontology. Dermokine, a gene of
unknown function, has been suggested to have a cytokine function,
which supports an epicardial signalling role [27]. A recent report
that dermokine is up-regulated in canine muscle after sustained
endurance exercise [28] suggests a possible involvement in muscle
adaptation. Its differential expression in the epicardium after
cardiac injury makes dermokine an interesting target for functional
studies in acute cardiac response to injury as well as to physiological
or pathological hypertrophy.
The transcription factor basonuclin-1 plays a role in epithelial
cell differentiation and proliferation and has been studied in a
corneal epithelium damage model [29]. Basonuclin-1 null mice
display reduced epithelial cell proliferation with thin epidermis
and delayed healing of the corneal epithelium. A likely role for this
epithelial stem cell marker in epicardial function is the support of
cell proliferation [30], a feature necessary for epicardial develop-
ment and homeostasis. Although basonuclin-null mice are viable,
Table 2. GO ontology analysis of epicardial signature genes.
GOID Term qm p
GO:0002526 acute inflammatory response 9 141 5.44*10‘–7
GO:0002541 activation of plasma proteins involved in acute inflammatory response 6 70 1.36*10‘–5
GO:0006956 complement activation 6 70 1.36*10‘–5
GO:0006692 prostanoid metabolic process 4 23 2.15*10‘–5
GO:0006693 prostaglandin metabolic process 4 23 2.15*10‘–5
GO:0045087 innate immune response 8 168 2.72*10‘–5
GO:0048869 cellular developmental process 36 3337 5.51*10‘–5
GO:0006959 humoral immune response 6 90 5.73*10‘–5
GO:0051605 protein processing by peptide bond cleavage 7 138 6.89*10‘–5
GO:0006958 complement activation, classical pathway 5 59 8.15*10‘–5
GO:0002455 humoral immune response mediated by circulating immunoglobulin 5 64 0.000123
GO:0007155 cell adhesion 18 1092 0.000123
GO:0022610 biological adhesion 18 1094 0.000123
GO:0002253 activation of immune response 7 154 0.00013
GO:0006954 inflammatory response 10 381 0.000287
GO:0030154 cell differentiation 33 3208 0.00035
GO:0002684 positive regulation of immune system process 10 393 0.000371
GO:0016485 protein processing 7 183 0.000395
GO:0048856 anatomical structure development 40 4332 0.000411
GO:0030198 extracellular matrix organization 7 188 0.000465
GO:0032502 developmental process 47 5527 0.00048
Epicardial GO ontology list included various innate immune system lists as well as the cell adhesion list, confirming the epithelial character of the epicardium. An FDR
cut off of 0.0005 was used. (q: number of epicardial genes present in the given GO list; m: total number of genes in a given GO list; p: FDR value for a given GO list
enrichment among the epicardial genes).
doi:10.1371/journal.pone.0011429.t002
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corneal epithelium, generally associated with increased rates of cell
invasiveness and EMT [31]. Should basonuclin play a similar role
in the epicardium, regulation of EMT during repair processes of
the heart may be compromised in these mice. We are currently
investigating this possibility.
Figure 3. Unsupervised analysis of epicardial gene expression post infarction. A) Self- organizing maps were used to derive six clusters two
of which, (3 and 4) contain genes that are strongly regulated. Cluster 3, includes epicardial signature genes whose expression decreases sharply in the
epicardium but remains low in muscle post-infarction. Cluster 4 contains epicardial signature genes that are largely unchanged in the epicardium but
are increased in muscle post-infarction. B) Heat map of data in A).
doi:10.1371/journal.pone.0011429.g003
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adhesiveness after induction of cardiac infarct is consistent with
cells undergoing EMT in the epicardium before myocardial
invasion, migration and differentiation into endothelial or smooth
muscle cells to form new vasculature. The upregulation of
vascularisation and epithelial genes in the muscle tissue further
supports this interpretation. Indeed, several markers for EMT
were affected in the epicardial as well as cardiac transcriptome
after injury. Together with activation of thymosin b-4 expression
in the epicardium samples [9], these data suggest that epicardial
cells may undergo global activation post-infarction. Without
further lineage tracing studies, the fate of epicardial cells after
infarction remains uncertain, as epicardial cells might alter their
gene expression profile without actually undergoing EMT.
Despite some similarities to gene programs activated in the
initial repair processes after resection of zebrafish hearts, the
mammalian epicardium cannot support effective regeneration of
cardiac damage. In this regard, the shift in epicardial gene
expression patterns in mice expressing supplemental mIGF-1
propeptide in the myocardium may support the improved
regenerative capacities documented in these transgenic hearts
[32]. Specifically, elevated RALDH2 expression in the epicardium
in response to supplemental mIGF-1 from the underlying
myocardium points to a novel homeostatic re-activation of
embryonic programs, in which the pivotal role of retinoic acid
in epicardial development is redeployed to prime the tissue for
more effective mobilization upon injury. A related study has been
published reporting epicardial transcriptional profiling of material
obtained by tissue digestion and subsequent physical removal of
the epicardial cell layer, confirming post-infarction reactivation of
RALDH2 and other embryonic genes that correlate well with the
present study [33].These observations will inform further investi-
gation of the altered gene programs elicited by supplemental
mIGF-1 propeptides to unravel their role in the enhancement of
mammalian cardiac repair. The epicardial signatures presented
here provide important tools for such analyses, as well as
important information for comparative studies to determine which
of the epicardial genes play crucial roles in the development,
homeostasis, or repair processes of the heart in other more
regenerative organisms.
Materials and Methods
Ethics Statement
All mouse procedures were approved by the EMBL Monter-
otondo Ethical Committee (Monterotondo, Italy) and were in
accordance with national and European regulations.
Animal keeping and Myocardial Infarction model
WT male C57/Bl6 mice were purchased from Charles River
Laboratories. Male mIGF-1 transgenic animals were used as
described before [32]. All animals used were mus musculus of
C57/Bl6 background. Animals were kept in IVC mouse racks
at a 12 h/12 h light-dark cycle and were fed with pellet food
and drinking water. Bedding material was changed once a
week.
Table 3. Downregulated epicardial signature genes after myocardial infarction.
p-value GenBank accession Gene Symbol Gene Description
0.0474 U88064 Bnc1 basonuclin 1
0.045 NM_021719 Cldn15 claudin 15
0.0356 AV347903 Gng4 guanine nucleotide binding protein (G protein), gamma 4
0.0286 AK004699 Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1
0.0241 BE945607 Cybrd1 cytochrome b reductase 1
0.0241 NM_008198 Cfb complement factor B
0.0208 AV288135 Atad4 ATPase family, AAA domain containing 4
0.0208 BB348674 Gpm6a glycoprotein m6a
0.0208 NM_026228 Slc39a8 solute carrier family 39 (metal ion transporter), member 8
0.0208 BB325766 Lrrn4 leucine rich repeat neuronal 4
0.0208 AK003577 Muc16 mucin 16
0.0208 NM_021426 Nkain4 Na+/K+ transporting ATPase interacting 4
0.0208 BC023060 Efemp1 epidermal growth factor-containing fibulin-like extracellular matrix protein 1
0.0142 K02782 C3 complement component 3
0.00681 BC022950 1600029D21Rik RIKEN cDNA 1600029D21 gene
0.00681 BC010782 Tm4sf5 transmembrane 4 superfamily member 5
0.00616 NM_008365 Il18r1 interleukin 18 receptor 1
0.00616 NM_138683 Rspo1 R-spondin homolog (Xenopus laevis)
0.00616 BB075402 Zdbf2 zinc finger, DBF-type containing 2
0.00249 AV012073 Rarres2 retinoic acid receptor responder (tazarotene induced) 2
0.00217 BB118542 Slc26a3 solute carrier family 26, member 3
0.00215 NM_007753 Cpa3 carboxypeptidase A3, mast cell
0.00196 AV144145 Chrdl1 chordin-like 1
Epicardial signature genes of Cluster 3 (Figure 3) were tested for statistically significant downregulation in the epciardium samples as described in Materials and
Methods. This list shows those genes that were downregulated (p value cut off: 0.005) in the epicardium samples.
doi:10.1371/journal.pone.0011429.t003
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anesthetized using 2% isoflurane and endo-tracheal intubation was
carried out to ventilate the lungs while the chest was open. An
incision of several mm length away from the sternal border towards
the left armpit was made. Underlying connective tissue was opened
and the two muscle layers underneath were spread and held by
retractors without incision into the muscle. The rib cage was then
visualized and opened at the 4
th intercostal space. The retractors
were inserted and the pericardium was cut open to allow access to
the heart. The left coronary artery was visualized running form the
left atrium towards the apex as a red pulsating vessel [34]. The
ligation was placed about 1 mm from the atrium to reach an
infarction size of 40–50% of the ventricle. Next an 8–0 ligature was
passed underneath the LAD and tied with three knots. For Sham
Table 4. Epicardial signature gene expression changes in muscle after myocardial infarction.
p-value GenBank accession Gene Symbol Gene Description
0.0497 BB558905 Bace2 beta-site APP-cleaving enzyme 2
0.0495 NM_033314 Slco2a1 solute carrier organic anion transporter family, member 2a1
0.0473 NM_009242 Sparc secreted acidic cysteine rich glycoprotein
0.0433 BF235516 Ptprf protein tyrosine phosphatase, receptor type, F
0.0433 AK011545 Basp1///LOC100045716 brain abundant, membrane attached signal protein 1///similar to 22 kDa
neuronal tissue-enriched acidic protein
0.0359 BB065799 Sulf1 sulfatase 1
0.0329 U08020 Col1a1 collagen, type I, alpha 1
0.0329 L36062 Star steroidogenic acute regulatory protein
0.0329 NM_010329 Pdpn podoplanin
0.0259 BF227507 Col1a2 collagen, type I, alpha 2
0.0211 AW550625 Col3a1 collagen, type III, alpha 1
0.0211 NM_011254 Rbp1 retinol binding protein 1, cellular
0.0211 NM_009636 Aebp1 AE binding protein 1
0.0175 BB392676 1500015O10Rik RIKEN cDNA 1500015O10 gene
0.0175 NM_011985 Mmp23 matrix metallopeptidase 23
0.0175 NM_013586 Loxl3 lysyl oxidase-like 3
0.0175 X16834 Lgals3 lectin, galactose binding, soluble 3
0.0174 BC022666 Mfap4 microfibrillar-associated protein 4
0.0147 BC008107 Timp1 tissue inhibitor of metalloproteinase 1
0.00893 M65143 Lox lysyl oxidase
0.00742 BC025600 Tmem119 transmembrane protein 119
Epicardial signature genes of Cluster 4 (from Figure 3) were tested for statistically significant upregulation in the muscle control samples as described in Materials and
Methods. This Table shows those genes that were upregulated (p value cut off: 0.005) in the muscle control samples.
doi:10.1371/journal.pone.0011429.t004
Table 5. New epicardial genes induced in mIGF-1 hearts.
Fold Difference Gene Symbol Gene Description
43.96 Pik3cd phosphatidylinositol 3-kinase catalytic delta polypeptide
34.41 Ptprk protein tyrosine phosphatase, receptor type, K
30.04 Rbbp8 retinoblastoma binding protein 8
27.13 Polr3k Polymerase (RNA) III (DNA directed) polypeptide K (Polr3k), mRNA
26.19 Nrip2 nuclear receptor interacting protein 2
25.8 Cryl1 crystallin, lambda 1
25.67 1700003E16Rik RIKEN cDNA 1700003E16 gene
22.52 H2-T10 histocompatibility 2, T region locus 10
22.26 1110069O07Rik RIKEN cDNA 1110069O07 gene
20.27 EG620313///Tbca predicted gene, EG620313///tubulin cofactor A
20.05 Marcksl1 MARCKS-like 1
IGF-1 and WT epicardial samples were compared to the underlying myocardium to examine variations in epicardial signature genes (as defined in Materials and
Methods). Several genes that had a .20 fold induction in the epicardium of mIGF-1 hearts were not at all represented in epicardial genes in WT hearts.
doi:10.1371/journal.pone.0011429.t005
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inserted into the heart. The retractors were removed and the chest
was closed by bringing together the 4
th and 5
th ribs using 6–0 nylon
sutures. The muscles were placedinto their original position and the
skin incision was closed using a 6–0 nylon suture. Mice were
monitored until awakening and body temperature was kept up by
red light. After surgery mice were kept individually in double cages
and sacrificed three or six days after surgery.
Laser Capture Microscopy (LCM). Hearts were excised
after perfusion with 40 ml Phosphate Buffer Saline (PBS) and
immediately frozen in OCT at 280uC. PEN membrane coated
slides (Carl Zeiss MicroImaging GmbH, Bernried, Germany) were
activated and prepared as suggested by the supplier. Seven mm
thick tissue sections of the left ventricle were obtained and washed
for 10 seconds in DEPC-treated water, precooled 70% EtOH and
100% EtOH. Slides were air dried for 1–2 min. and stored at
280uC until processing. For laser dissection, slides were thawed
briefly and excess liquid was removed. The epicardial samples, as
well as cardiac muscle controls, were independently dissected out
using a P.A.L.M. LCM (Carl Zeiss MicroImaging GmbH,
Bernried, Germany) as shown in Figure S1.
For non-infarcted samples (sham operated), epicardial cells were
obtained by dissecting the epicardial and subepicardial layer of the
left ventricle. For infarcted samples, the infarction was carried out
as described in the corresponding section and animals were
sacrificed for dissection three or six days after induced infarction.
Epicardial cells were dissected partly above and partly below the
site of infarction using the infarct-suture site as landmark. Laser
capture dissection represents the most reproducible way of
collecting epicardial sample without introducing a bias towards
certain cell populations (FACS sorting) or compromising RNA
quality through prolonged tissue handling (staining). Fragments
were catapulted into microtube lids filled with 65 ml RLT buffer
(Qiagen, Milano, Italy) and 5 ml of carrier RNA (4 ng/ml solution).
RNA isolation
After dissection, total RNA ofthe epicardial layer of individual hearts
were isolated using a standard RNeasy micro kit (Qiagen, Milano, Italy)
protocol. Quality of RNA was tested using Agilent Bioanalyzer 2100
(Agilent Technologies Inc., Santa Clara, USA). RIN values were at
least above 6 while most samples had a RIN between 7 and 8. For each
sample between 0.2 and 2 ng of RNA could be collected.
Figure 4. Unsupervised analysis of epicardial gene expression changes post infarction in IGF-1 animals. Self- organizing maps were
used to derive six clusters of epicardial genes for IGF-1 overexpressing mice. Unlike for the wildtype animals, no cluster contained extensive
expression changes post infarction.
doi:10.1371/journal.pone.0011429.g004
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RNA was processed for Affymetrix GeneChip analysis by the
gene core facility at the European Molecular Biology Laboratory
(EMBL) using a two cycle cDNA synthesis protocol as suggested by
the supplier (Affymetrix, Santa Clara, CA) and a mouse430-2.0
chip (Affymetrix, Santa Clara, CA) was used for the analysis.
Gene array data analysis and statistics
Data was processed and analysed using GeneSpring GX 7.3.1
(Agilent, Waldbronn, Germany). Gene array raw data was first
normalized in order to make multiple chip data comparable using
the pre-processing algorithm ‘‘GeneChip - Robust Multi-Array
Average’’ (GC-RMA) method to account for background correc-
tion, normalization, and summarization. For further normal-
ization values below 0.01 were set to 0.01. Each measurement was
divided by the 50.0th percentile of all measurements in that
sample. Each gene was divided by the median of its measurements
in all samples. If the median of the raw values was below 10 then
each measurement for that gene was divided by 10 if the
numerator was above 10, otherwise the measurement was
excluded. For each experimental group of tissues, samples from
four or five animals were used. All array data is MIAME
compliant and raw data has been deposited with ArrayExpress
(Accession number: E-MEXP-2446).
Cluster Analysis
Gene clusters representing similar expression profiles between
uninjured epicardial and muscle control samples were identified
using unsupervised, SOM clustering (Radius 7.0) with a maximum
of 4500000 iterations. SOM clustering can be used to partition
genes into clusters of similar gene expression changes across
samples. In this analysis, only relative changes in expression levels
are considered. Dimensions of 262 were chosen as this results in 4
clusters with discernible differences. Unsupervised SOM clustering
for post infarction expression changes were carried out using an
expanded 263 matrix, 10000 iterations, and a radius of 4.0. This
expansion was necessary to account for the increased number of
possible gene expression patterns that one can envision in the
infarcted animals.
Analysis of epicardial genes and differentially regulated
genes post infarction
A list of WT epicardium-enriched genes was created by a
parametric t-test using the Benjamini-Hochberg method to correct
for multiple testing with a false discovery rate of 0.05 starting from
SOM cluster 1 (from Figure 1). An epicardial signature gene list
was derived from genes with a normalized .4-fold increased
expression in the epicardial sample compared to the muscle
control and a raw expression of at least 20 in the epicardial
samples. We identified 197 unique genes that fulfilled these criteria
and were thus considered epicardial signature genes. When
comparing directly the mIGF-1 epicardial genes to WT signature
genes, we applied statistical analysis for both as described above
without prior use of unsupervised testing in order to maximize
comparability between the two genotypes. For analysis of
differentially regulated epicardial genes after infarction, clusters
(3,1) and (1,2) were used. All statistical parameters and tests were
used as described above.
GO Analysis
For GO analysis, gene lists were analysed using the GOEAST
online tool [35]. Hypergeometric testing was used with Benjamini
& Yekutieli method for multiple testing correction using a
maximum FDR of 0.005. For the analysis of the epicardial
samples, the complete list of 197 epicardial signature genes was
used as input (Table S1). For GO analysis of expression changes
post infarction, the lists of statistically significantly regulated genes
were used as input (Tables 3 and 4).
For further classification of the expression changes after
infarction, KEGG analysis was also attempted, but no significantly
enriched pathways could be identified.
qRT-PCR
Isolated RNA was reverse transcribed using TaqMan Reverse
transcription reagents (Applied Biosystems, Foster City, CA).
Quantitative PCR was carried out using Applied Biosystems gene
expression Taqman assays on a ABI PRISM 7700 Sequence
Detector (Applied Biosystems, Foster City, CA). Samples were
incubated at 50uC for 10 min, 95uC for 2 min and amplified for
40 cycles (95uC: 15 sec, 60uC: 1 min). Results were normalized
against expression of the 18 S ribosomal RNA.
Statistics and calculation for qRT-PCR
For quantitative reverse transcription PCR, expression was
analysed by normalizing against expression levels of 18 S
transcripts. To transform Ct values to relative expression values,
the following formula was used :
Relative expression =2‘ -(DCt - Ct[stable]).
Where: DCt : Ct[Gene of Interest] – Ct[18 S]
Ct[stable]: Ct of one constant sample across all Ct’s for the same
gene.
Statistical significance was tested using student t-test (tail 2, type
2). Expression values are mean relative expression or mean fold
induction 6 standard error of the mean (SEM). A p value ,0.05
was considered statistically significant unless noted otherwise.
(*: p,0.05; **: p,0.005; ***: p,0.0005).
Immunohistochemistry
Unfixed mouse heart sections were immersed at room
temperature in 100% precooled Acetone for 10 minutes. Samples
were washed three times with PBS for 3 minutes each and blocked
with blocking solution containing 3% BSA in PBS for 30 minutes.
Antibodies were applied at the appropriate dilution (rabbit anti-
dermokine at 1:250 (Abcam, Cambridge, MA), rat anti-GPM6A at
1:100 (MBL International, Woburn, MA)) diluted in 3% BSA in
PBS. Sections were incubated with primary antibodies overnight
at 4 uC and washed three times in PBS for 5 minutes. Secondary
antibody (Dermokine : Alexa goat anti rabbit 594 (Invitrogen,
Carlsbad, CA); GPM6A - Alexa rabbit anti rat 594 (Invitrogen,
Carlsbad, CA) was diluted in PBS at 1:1000 dilution and
incubated for 1 hr at room temperature. Slides were washed
twice with DAPI (1:20,000) in PBS for 5 minutes and mounted
with Permafluor mounting medium (Beckman Coulter, Fullerton,
CA). Basonuclin stains were carried out on paraffin embedded
sections. Isolated tissues were fixed overnight at 4uCi n4 %
Formaldehyde/H2O solution. Tissues were gradually dehydrated
(washes in PBS, 0.85% saline, 1:1 saline/100%EtOH, 2670%
EtOH, 85% EtOH, 95% EtOH, 100% EtOH at 4uC). For further
dehydration slides were incubated twice at room temperature in
100% Xylene and then 1:1 xylene/paraffin, before they were
subjected to 6 changes of 100% paraffin. Tissues were then placed
into tissue block molds filled with paraffin. After letting stand over
night to harden, 10 mm thick sections were cut using a microtome
and placed on SuperFrost Plus microscope slides (Thermo
Scientific, Germany). Slides were then left to dry at 42uC
overnight. Before starting the staining protocol, slides were
rehydrated through an ethanol series (100%.70%). They were
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slides were placed in BG antigen retrieval solution (PickCell
Laboratories, USA) and processed in a pressure cooker ‘‘Retriever
2100’’ (PickCell Laboratories, USA) as described in the protocol
and left to cool down over night. Sections were incubated in 0.5%
H2O2/dH2O for 10 minutes and then incubated in 5% normal
horse serum for one hour at RT. After removing the serum, anti-
basonuclin antibody (Santa Cruz) was applied at 1/50 dilution and
incubated (1 h at RT for basonuclin antibody) in a moisturized
chamber and washed three times in PBS. As secondary antibodies,
peroxidase conjugated antibodies were used for 1 h at RT. Slides
were then washed three times in PBS and were incubated in DAB
substrate (SK4100, Vector Laboratories, USA) as described in the
protocol. Slides were then rehydrated through an ethanol series
(70%,100%) and mounted after three washes in Xylene.
Supporting Information
Figure S1 Isolation of the epicardial cell layer of murine hearts
using laser capture microscopy. A) Hearts were frozen and cut in a
cryostat at 7mJm thickness, washed in DEPC treated water, 70%
EtOH and finally 100% EtOH. B) The epicardial surface of the
sections was laser excised (dissected area denoted E) and
catapulted into RNA stabilizing solution for later RNA isolation.
C) Cardiac muscle (excised area denoted M) was excised to
compare gene expression of the epicardial layer to the rest of the
heart. (Scale bar: 200mm).
Found at: doi:10.1371/journal.pone.0011429.s001 (4.49 MB
TIF)
Figure S2 Comparative analyses of epicardial signature genes.
Epicardial data was compared to muscle control, left ventricle or
whole heart gene array data. For each of the three control groups,
a list of epicardial genes was generated using the same conditions.
These lists were compared using a Venn diagram, showing that
most genes were overlapping between the different comparison
approaches (see Table S2). Especially highly expressed epicardial
signature genes were found in all three approaches (white area),
confirming our findings of epicardial genes.
Found at: doi:10.1371/journal.pone.0011429.s002 (0.16 MB
TIF)
Figure S3 Confirmation of post-infarction gene expression
changes. RT-PCR analysis of epicardial signature gene expression
changes post-infarct confirmed expression differences between
three and six days post infarction were mostly negligible. In
contrast, CD5L was upregulated three days post infarction but
returned to basal expression levels after six days, highlighting the
importance of immune response genes in early post infarction
processes. GALDH was used as control. (S: Sham operated, 3:
three days post infarction, 6: six days post infarction; *: p,0.05;
***: p,0.0005; errors are S.E.M.).
Found at: doi:10.1371/journal.pone.0011429.s003 (0.36 MB TIF)
Table S1 Full List of epicardial signature genes.
Found at: doi:10.1371/journal.pone.0011429.s004 (0.04 MB
XLS)
Table S2 Comparative analyses of epicardial signature genes.
Data supporting Figure S2.
Found at: doi:10.1371/journal.pone.0011429.s005 (0.05 MB
XLS)
Table S3 Full GO analysis of epicardial signature genes.
Analysis of genes with a p-value cut off of 0.005.
Found at: doi:10.1371/journal.pone.0011429.s006 (0.02 MB
XLS)
Table S4 GO analysis of downregulated epicardial signature
genes after myocardial infarction. Analysis of genes with a p-value
cut off of 0.005.
Found at: doi:10.1371/journal.pone.0011429.s007 (0.01 MB
XLS)
Table S5 GO analysis of upregulated epicardial signature genes
in muscle after myocardial infarction. Analysis of genes with a p-
value cut off of 0.005.
Found at: doi:10.1371/journal.pone.0011429.s008 (0.03 MB
XLS)
Table S6 List of mIGF-1 epicardial signature genes.
Found at: doi:10.1371/journal.pone.0011429.s009 (0.09 MB
XLS)
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